Connect Biopharma Holdings (CNTB) Accumulated Expenses (2023 - 2025)
Historic Accumulated Expenses for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $8.9 million.
- Connect Biopharma Holdings' Accumulated Expenses changed N/A to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $7.8 million for FY2024, which is 1769.17% down from last year.
- Per Connect Biopharma Holdings' latest filing, its Accumulated Expenses stood at $8.9 million for Q3 2025.
- Over the past 5 years, Connect Biopharma Holdings' Accumulated Expenses peaked at $9.5 million during Q4 2023, and registered a low of $7.2 million during Q1 2025.
- Moreover, its 3-year median value for Accumulated Expenses was $7.9 million (2025), whereas its average is $8.3 million.
- Examining YoY changes over the last 5 years, Connect Biopharma Holdings' Accumulated Expenses showed a top increase of 1769.17% in 2024 and a maximum decrease of 1769.17% in 2024.
- Over the past 3 years, Connect Biopharma Holdings' Accumulated Expenses (Quarter) stood at $9.5 million in 2023, then fell by 17.69% to $7.8 million in 2024, then rose by 14.48% to $8.9 million in 2025.
- Its Accumulated Expenses stands at $8.9 million for Q3 2025, versus $7.9 million for Q2 2025 and $7.2 million for Q1 2025.